Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9EAP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,355
Award facts
- Contract value 100% obligated
- $15,355.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 30, 2026, for $15,355.44 to supply Kesimpta 20 mg/0.4 mL pen injections, with delivery completion required by February 2, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a task order issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031, serving as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor with an extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains. Through its parent company's comprehensive IDC with DLA, the company supplies specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military treatment facilities, the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Kesimpta delivery represents a routine pharmaceutical supply transaction consistent with the company's role as a prime vendor in the DLA's global pharmaceutical support network.
Quick answers
Who was awarded contract SPE2DR26F9EAP?
SPE2DR26F9EAP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F9EAP worth?
The government has obligated $15,355 on SPE2DR26F9EAP.
Is contract SPE2DR26F9EAP an order under another contract?
Yes. SPE2DR26F9EAP is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9EAP competed?
The extent of competition for SPE2DR26F9EAP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award